Novavax Inc. expects regulators in India, the Philippines, and elsewhere to make a decision on its COVID-19 vaccine within “weeks,” its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.
Novavax shares were up about 13 percent after the company also said it had filed an application for emergency use of the vaccine to Canada and the European Medicines Agency.
